NOVYRA PHARMACHEM LIMITED
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 |
|---|---|---|---|
| Revenue | 4.27 | 1.73 | 0.10 |
| Operating Expense | 4.30 | 1.74 | 5.44 |
| Net Profit | -0.03 | -0.02 | -5.34 |
| Net Profit Margin | -0.70% | -1.16% | -5,340% |
| Earning Per Share | -0.05 | -0.03 | -8.43 |
| EBIDTA | -0.03 | -0.02 | -5.33 |
| Effective Tax Rate | -0% | -0% | -0% |
Particulars
Sep 2026
Revenue4.27
Operating Expense4.30
Net Profit-0.03
Net Profit Margin-0.70
Earning Per Share-0.05
EBIDTA-0.03
Effective Tax Rate-0
